The U.S. online prescription drug platform had planned to sell 34.6 million shares in its IPO at a target range of $24 and $28 per share.
GoodRx did not immediately respond to a request for comment.
GoodRx sells shares in IPO above target range – source
4 years ago
No Comments
Related Posts
Netflix and AMC can get along fine, actually, as ‘Glass Onion’ hints at more cooperation to come
October 6, 2022
How a top Citi banker works from home
April 8, 2020
Don’t click that Zoom invitation!
August 19, 2020
‘Singapore has a new visa that will target expat ‘rainmakers’—are you what they’re looking for?’
September 6, 2022
New York City lifeguards are about to get a 20% pay increase amid nationwide labor shortage
July 6, 2022
How top CEOs from Elon Musk to Tim Cook tackled the big return-to-office in 2022
December 26, 2022
About The Author
